98 related articles for article (PubMed ID: 2690615)
1. In vitro activity of ofloxacin against Chlamydia trachomatis.
Schachter J; Moncada JV
Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
[TBL] [Abstract][Full Text] [Related]
2. The role of fluoroquinolones in sexually transmitted diseases.
Tartaglione TA; Hooton TM
Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
[TBL] [Abstract][Full Text] [Related]
3. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
7. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Dailloux M; Villemain P
Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
Harrison HR; Riggin RM; Alexander ER; Weinstein L
Am J Obstet Gynecol; 1984 Jul; 149(5):477-80. PubMed ID: 6742014
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
15. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of ofloxacin against Chlamydia trachomatis.
Sambri V; Rumpianesi F; Xerri L; Cevenini R
J Chemother; 1989 Aug; 1(4):231-2. PubMed ID: 2809689
[TBL] [Abstract][Full Text] [Related]
18. Activity of thiamphenicol against Chlamydia trachomatis and Neisseria gonorrhoeae.
Ridgway GL; Felmingham D; Mumtaz G; O'Hare M
Sex Transm Dis; 1984; 11(4 Suppl):432-4. PubMed ID: 6441286
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Slaney L; Chubb H; Ronald A; Brunham R
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]